Form 4 for BSX Boston Scientific
Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-03 · accession 0001225208-25-008911 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-04 | 2025-11-03 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $99.47 | -50.0K | 224.7K | -18% | -$4.97M |
| D | 2025-11-04 | 2025-11-03 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $26.15 | +50.0K | 228.3K | +28% | +$1.31M |
| D | 2025-11-04 | 2025-11-03 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | S | D | 16,928 | $99.76 | 207,814 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $99.59 to $100.53, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-11-03 | S | D | 29,472 | $99.14 | 178,342 | D | — | — | (F4) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.57 to $99.54, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-11-03 | S | D | 3,600 | $100.75 | 224,742 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.72 to $100.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-11-03 | M | A | 50,000 | $26.15 | 228,342 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-03 | M | D | 50,000 | $0.00 | 0 | D | $26.15 · — to 2027-12-01 | 50,000 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2018, the first anniversary of the date of grant. |